Inventor
Anne B. Eldrup
Inventor
Danbury, CT, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Hprimary
C07HSugars24%
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C12NMicroorganisms or enzymes14%
C07DHeterocyclic compounds12%
Y02PClimate change mitigation technologies in the production or processing of goods12%
C07KPeptides4%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
11,078,485Compositions comprising alternating 2'-modified nucleosides for use in gene modulation202110,266,825Compositions comprising alternating 2'-modified nucleosides for use in gene modulation20199,771,578'Phosphorous-linked oligomeric compounds and their use in gene modulation'20179,150,605'Compositions comprising alternating 2′-modified nucleosides for use in gene modulation'20159,150,606'Compositions comprising alternating 2\'-modified nucleosides for use in gene modulation'20158,604,183'Compositions comprising alternating 2′-modified nucleosides for use in gene modulation'20138,481,712'Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase'20138,258,301'Urotensin II receptor antagonists'20127,919,612'2′-substituted oligomeric compounds and compositions for use in gene modulations'20117,812,149'2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations'20107,534,767'C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase'20097,323,453'Methods of inhibiting orthopoxvirus replication with nucleoside compounds'20087,202,224'Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase'20077,125,855'Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase'20067,105,499'Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase'20066,777,395'Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus'20046,632,919'Peptide nucleic acid monomers and oligomers'20036,617,422'Peptide nucleic acid monomers and oligomers'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2015Patents assigned to ISIS PHARMACEUTICALS INC (11)· patent assignee history
2004–2009Patents assigned to MERCK & CO INC (4)· patent assignee history
2004–2013Based in Encinitas, CA, US· patent location history
2008–2015Based in Danbury, CT, US· patent location history
2010–2013Based in Ridgefield, CT, US· patent location history
2013–2015Patents assigned to BHAT BALKRISHEN (4)· patent assignee history
2013–2015Patents assigned to ELDRUP ANNE B (4)· patent assignee history
2013–2015Patents assigned to ALLERSON CHARLES (3)· patent assignee history
2017–2019Based in Newtown, CT, US· patent location history
2021Based in Newtown, PA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ISIS PHARMACEUTICALS INC | 11 | 2004–2015 |
| BHAT BALKRISHEN | 4 | 2013–2015 |
| ELDRUP ANNE Bself | 4 | 2013–2015 |
| MERCK & CO INC | 4 | 2004–2009 |
| ALLERSON CHARLES | 3 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Danbury, CT, US | 5 | 2008–2015 |
| Encinitas, California, US | 5 | 2004–2013 |
| Ridgefield, CT, US | 3 | 2010–2013 |
| Newtown, CT, US | 2 | 2017–2019 |
| Newtown, Pennsylvania, US | 1 | 2021 |